CoChat
Sign Up
Cited by 94

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Human papillomaviruses and the specificity of PDZ domain targeting

Pim, David, Bergant, Martina, Boon, Siaw S., Ganti, Ketaki, Kranjec, Christian, Massimi, Paola, Subbaiah, Vanitha K., Thomas, Miranda, Tomaić, Vjekoslav, Banks, Lawrence·2012·The FEBS Journal
DOI 10.1111/j.1742-4658.2012.08709.x
Open this paper in CoChat — free account

Abstract

The human papillomavirus (HPV) E6 oncoprotein is fundamental to the ability of these viruses to induce human malignancy. A defining characteristic of the HPV E6 oncoproteins found in cancer‐causing HPV types is the presence of a PDZ binding motif at their extreme C‐terminus. Through this motif, E6 is able to interact with a large number of cellular proteins that contain PDZ domains. Many of these cellular proteins are involved in regulation of processes associated with the control of cell attachment, cell proliferation, cell polarity and cell signaling. How E6 targets multiple proteins containing the same recognition domain is still an open question. In this review, we highlight aspects of E6 function and biology that help to answer this question, and thereby provide insight into the role of these substrates during development of HPV‐induced malignancy.

Overview

Integrity signals

Registry

Crossref · 10.1111/j.1742-4658.2012.08709.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 4 references

Research works printed but not linked: 55

  1. 10.1038/nrc798 · DOI
  2. 10.3322/canjclin.55.2.74 · DOI
  3. 10.1073/pnas.83.13.4680 · DOI
  4. 10.1002/j.1460-2075.1987.tb04849.x · DOI
  5. 10.1073/pnas.97.23.12513 · DOI · Paper page
  6. 10.1038/sj.onc.1206894 · DOI · Paper page
  7. 10.1016/j.ymthe.2003.08.004 · DOI · Paper page
  8. Barbosa MS, 1989, The E6 and E7 genes of HPV‐18 are sufficient for inducing two‐stage in vitro transformation of human keratinocytes, Oncogene, 4, 1529
  9. 10.1099/0022-1317-74-4-755 · DOI
  10. 10.1016/0042-6822(89)90595-3 · DOI · Paper page
  11. 10.1128/MCB.20.19.7059-7067.2000 · DOI
  12. Zerfass‐Thome K, 1996, Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein, Oncogene, 13, 2323
  13. 10.1101/gad.11.16.2090 · DOI · Paper page
  14. Ciccolini F, 1997, Functional studies of E7 proteins from different HPV types, Oncogene, 9, 2633
  15. 10.1006/viro.1996.0008 · DOI
  16. 10.1038/sj.onc.1202953 · DOI
  17. 10.1038/sj.onc.1202223 · DOI · Paper page
  18. 10.1006/viro.1999.0106 · DOI · Paper page
  19. 10.1128/JVI.00881-07 · DOI · Paper page
  20. 10.1038/sj.onc.1203375 · DOI
  21. 10.1128/jvi.68.7.4262-4273.1994 · DOI · Paper page
  22. 10.1016/j.virol.2006.08.038 · DOI · Paper page
  23. 10.1073/pnas.94.13.6670 · DOI · Paper page
  24. 10.1073/pnas.94.21.11612 · DOI · Paper page
  25. 10.1242/jcs.00809 · DOI
  26. 10.1128/JVI.77.12.6957-6964.2003 · DOI
  27. 10.1128/JVI.78.22.12366-12377.2004 · DOI · Paper page
  28. 10.1128/MCB.20.21.8244-8253.2000 · DOI · Paper page
  29. 10.1111/j.1742-4658.2012.08729.x · DOI
  30. 10.1111/j.1742-4658.2012.08699.x · DOI
  31. 10.1128/JVI.01756-10 · DOI
  32. 10.1128/JVI.01712-06 · DOI
  33. 10.1128/JVI.79.7.4229-4237.2005 · DOI
  34. 10.1128/JVI.00114-11 · DOI
  35. 10.1038/sj.onc.1205668 · DOI
  36. 10.1128/JVI.74.20.9680-9693.2000 · DOI
  37. 10.1242/jcs.02560 · DOI
  38. 10.1128/JVI.02545-06 · DOI
  39. 10.1128/JVI.01979-06 · DOI
  40. 10.1099/vir.0.83123-0 · DOI
  41. 10.1128/JVI.02188-07 · DOI
  42. 10.1038/sj.onc.1209837 · DOI
  43. Hampson L, 2004, The PDZ protein Tip‐1 is a gain‐of‐function target of the HPV16 E6 oncoprotein, Int J Oncol, 25, 1249
  44. 10.1038/onc.2008.351 · DOI · Paper page
  45. 10.1042/BJ20110903 · DOI · Paper page
  46. 10.1038/sj.onc.1208757 · DOI · Paper page
  47. 10.1128/JVI.02044-06 · DOI
  48. 10.1016/j.str.2012.02.001 · DOI · Paper page
  49. 10.1099/0022-1317-67-9-1909 · DOI
  50. 10.1038/sj.onc.1203988 · DOI
  51. 10.1038/sj.emboj.7600578 · DOI
  52. 10.1038/sj.onc.1209457 · DOI
  53. 10.1074/jbc.M607057200 · DOI
  54. 10.1074/jbc.M809304200 · DOI
  55. 10.1016/j.virol.2009.02.030 · DOI

Cited by

Metadata

Authors
Pim, D., Bergant, M., Boon, S. S., Ganti, K., Kranjec, C., Massimi, P., Subbaiah, V. K., Thomas, M., Tomaić, V., & Banks, L.
Venue
The FEBS Journal
Publisher
Wiley
Published
2012-08-29
Volume
279
Issue
19
Pages
3530-3537
ISSN
  • 1742-464X
  • 1742-4658
DOI
10.1111/j.1742-4658.2012.08709.x
Cited by
94
References
4
Language
en
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review